Prevalence of Diabetes in Persons with Disabilities in Primary Care
Tóm tắt
This research was designed to answer the question: Does the prevalence of diabetes differ between adults with and without disability, in the same family medicine practice? A retrospective cohort design was used, to study diabetes among adults, with sensory, trauma, developmental, and psychiatric disabilities so comparisons can be made between disability groups and to comparison patients without disabilities. There was a 5.3 fold risk for diabetes, given obesity, for patients with sensory disabilities, a 3.6 fold risk for patients with trauma disabilities, a 4.1 fold risk for adults with developmental disabilities, and a 3.1 fold risk for adults with psychiatric disability, compared to those with the same disability without obesity. The general principle that obesity is a major risk factor for the onset of Type 2 diabetes holds true and the actual risk for diabetes given obesity, is not significantly different between patients with and without disability.
Tài liệu tham khảo
American Diabetes Association (2004). Standards of medical care in diabetes. Diabetes Care, 27(Supplement 1), S15–S35.
Bowers, B., Esmond, S., Lutz, B., & Jacobson, N. (2003). Improving primary care for persons with disabilities: The nature of expertise. Disability & Society, 18(4), 443–455.
Dejong, G., Palsbo, S. E., Beatty, P. W., Jones, G. C., Knoll, T., & Neri, M. T. (2002). The organization and financing of health services for persons with disabilities. Milbank Quarterly, 80(2), 261–301.
Eriksson, K. F., & Lindgärde, F. (1991). Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. Diabetologia, 34, 891–898.
Gans, B. M., Mann, N. R., & Becker, B. E. (1993). Delivery of primary care to the physically challenged. Archives of Physical Medicine and Rehabilitation, 77, S15–S19.
Iezzoni, L. I., McCarty, E. P., Davis, R. B., & Siegens, H. (2000). Mobility impairments and use of screening and preventive services. American Journal of Public Health, 90, 955–961.
Pan, X. R., Li, G. W., Hu, Y. H., Wang, J. X., Yang, W. Y., An, Z. X., et al. (1997). Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. Diabetes Care, 20, 537–544.
Ryan, M. C., Collins, P., & Thakore, J. H. (2003). Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. American Journal of Psychiatry, 160(2), 284–289, Feb.
Sernyak, M. J., Leslie, D. L., Alarcon, R. D., Losonczy, M. F., & Rosenheck, R. (2002). Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. American Journal of Psychiatry, 159(4), 561–566.
The Diabetes Prevention Program Research Group (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine, 346, 393–403.
Tuomilehto, J., Lindstrom, J., Eriksson, J. G., Valle, T. T., Hamalainen, H., Ilanne-Parikka, P., et al. (2001). Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New England Journal of Medicine, 344, 1390–1392.
US Department of Health & Human Services (2000). Healthy people 2010, conference edn (vol. 1). Washington DC: US Government Printing Office.